Results 1 to 10 of about 67,859 (248)
BMJ Global Health, 2022 Introduction Estimating COVID-19 cumulative incidence in Africa remains problematic due to challenges in contact tracing, routine surveillance systems and laboratory testing capacities and strategies.
+90 more
doaj +2 more sources
PLoS Medicine, 2022 BackgroundOur understanding of the global scale of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data underestimate infection and cannot infer on population immunity; there is a ...
Isabel Bergeri +29 more
doaj +2 more sources
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Nature Communications, 2020 Healthcare workers may be at higher risk of SARS-CoV-2 infection than the general population. Here, the authors report 19% seroprevalence of SARS-CoV-2 antibodies among 2,149 employees in a Swedish hospital.
Ann-Sofie Rudberg +23 more
doaj +2 more sources
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
BMJ Open, 2021 Objectives We aimed to review SARS-CoV-2 seroprevalence studies conducted in Europe to understand how they may be used to inform ongoing control strategies for COVID-19.Design Scoping review of peer-reviewed publications and manuscripts on preprint ...
Rebecca Grant +6 more
doaj +2 more sources
MMWR. Morbidity and mortality weekly report, 2022 In December 2021, the B.1.1.529 (Omicron) variant of SARS-CoV-2, the virus that causes COVID-19, became predominant in the United States. Subsequently, national COVID-19 case rates peaked at their highest recorded levels.* Traditional methods of disease ...
K. Clarke +8 more
semanticscholar +1 more source
Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
Emerging Infectious Diseases, 2023 We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%).
Rebecca A. Falender +4 more
doaj +1 more source
Serological Evidence of Exposure to Globally Relevant Zoonotic Parasites in the Estonian Population. [PDF]
PLoS ONE, 2016 We investigated Estonian population and its selected subgroups for serological evidence of exposure to Ascaris lumbricoides, Echinococcus spp., Taenia solium, Toxocara canis, Toxoplasma gondii, and Trichinella spiralis.
Brian Lassen +7 more
doaj +1 more source
Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children
Swiss Medical Weekly, 2023 BACKGROUND: Much remains unknown regarding the evolution of SARS-CoV-2 seroprevalence and variability in seropositive children in districts, schools and classes as only a few school-based cohort studies exist.
Sarah R. Haile +6 more
doaj +1 more source
Seroprevalence of Noroviruses in Swine [PDF]
Journal of Clinical Microbiology, 2005 ABSTRACT Noroviruses (NVs) are important human pathogens that cause acute gastroenteritis. Genetically related animal enteric NVs have also been described, but there is no evidence of interspecies transmission of NVs. In this study we characterized antibody prevalence among domestic pigs by using recombinant capsid antigens of two human NVs ...
Tibor Farkas +7 more
openaire +3 more sources
Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown
BMC Infectious Diseases, 2022 Highlights 1. Two months after the COVID-19 outbreak in Wuhan, the seroprevalence for IgM and IgG in the convalescent patients was 31.82% and 77.27%, respectively.
Yueting Tang +10 more
doaj +1 more source